Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPY2R | P49146 | 8/20 | 0.62 |
| ▸ | NPY4R | P50391 | 8/20 | 0.62 |
| ▸ | NPY5R | Q15761 | 8/20 | 0.62 |
| ▸ | NPY1R | P25929 | 6/20 | 0.62 |
| ▸ | CALCR | P30988 | 4/20 | 0.60 |
| ▸ | CXCR4 | P61073 | 1/20 | 0.56 |
| ▸ | APLNR | P35414 | 1/20 | 0.56 |
| ▸ | MAPK8 | P45983 | 1/20 | 0.56 |
| ▸ | MAPK9 | P45984 | 1/20 | 0.56 |
| ▸ | MAPK10 | P53779 | 1/20 | 0.56 |
| ▸ | HCRTR1 | O43613 | 1/20 | 0.56 |
| ▸ | HCRTR2 | O43614 | 1/20 | 0.56 |
| ▸ | TFPI | P10646 | 1/20 | 0.55 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30537477 | 0.91 | NPY2R (0.65) | NPY2RNPY4RNPY5RNPY1RCALCR | |
| SCHEMBL30495627 | 0.91 | NPY2R (0.64) | NPY2RNPY4RNPY5RNPY1RCALCR | |
| SCHEMBL30495794 | 0.90 | CALCR (0.65) | NPY2RNPY4RNPY5RNPY1RCALCR | |
| SCHEMBL29903311 | 0.90 | CALCR (0.60) | NPY2RNPY4RNPY5RNPY1RCALCR | |
| SCHEMBL29498111 | 0.90 | CALCR (0.64) | NPY2RNPY4RNPY5RNPY1RCALCR | |
| SCHEMBL30932059 | 0.89 | NPY2R (0.68) | NPY2RNPY4RNPY5RNPY1RCALCR | |
| SCHEMBL30932056 | 0.89 | NPY2R (0.68) | NPY2RNPY4RNPY5RNPY1RCALCR | |
| SCHEMBL30932058 | 0.89 | NPY2R (0.68) | NPY2RNPY4RNPY5RNPY1RCALCR | |
| SCHEMBL30932084 | 0.89 | NPY2R (0.68) | NPY2RNPY4RNPY5RNPY1RCALCR | |
| SCHEMBL31409140 | 0.89 | APLNR (0.55) | NPY2RNPY4RNPY5RNPY1RCALCR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3250180-B1 | PHARMACEUTICAL COMPOSITION COMPRISING VITAMIN K2 FOR USE IN THE TREATMENT OR PREVENTION OF MELANOMA | LESAFFRE & CIE (FR) | 2026-03-11 | — | — | EP | disclosed |